Forecasting models account for clinical and epidemiological drivers of oncology medicine demand. However, NHS operational pharmacy processes also determine how medicines are delayed, reduced, shared, compounded, and wasted in practice, often creating meaningful gaps between forecasted and observed utilisation.
Drawing on new primary market research conducted with senior NHS oncology pharmacy professionals across major oncology centres in England, this webinar explores the internal operational processes behind oncology medicines handling, and the impact each has on forecasting assumptions and real-world utilisation patterns.
Hosted by Verpora alongside NHS contributors involved directly in the research, the session will unpack how dose banding, treatment delays, dose reductions, vial sharing, compounding pathways, and wastage influence observed utilisation, and share practical recommendations for improving forecasting assumptions.
+ exclusive to webinar registrants and attendees
Oncology Medicines Handling in NHS Hospitals: Implications for Forecasting High-Cost Oncology Medicines
Register now to guarantee access.
Register Now
Attendance is complimentary for eligible pharmaceutical manufacturer personnel.
In this webinar we’ll unpack the findings from Verpora’s report, combining analysis from the Verpora team with practical interpretation from NHS oncology pharmacy professionals who contributed directly to the research interviews:
If your remit includes forecasting, interpreting oncology utilisation data, or understanding variability in observed medicine usage, this webinar will provide:
Clearer understanding of how internal NHS operational processes influence real-world utilisation patterns
Practical insight into the operational factors driving divergence between forecasted and observed utilisation
Better context for interpreting dose banding, vial sharing, treatment delays, dose reductions, and wastage within utilisation datasets
Greater confidence in pressure-testing forecasting assumptions and patient-to-volume conversion models
Frontline perspectives from NHS oncology pharmacy professionals involved directly in medicines handling and operational delivery
Format & Duration
30-minute live presentation and panel discussion
15-minutes audience Q&A
Who Should Attend?
This online masterclass is open exclusively to personnel from pharmaceutical manufacturers working within…
| Oncology Business Unit Leadership | Business Insights | Analytics |
| Forecasting | Brand & Franchise Leadership | Finance |
| Commercial Strategy | Pricing | Supply Chain |
Register Now
Attendance is complimentary for eligible pharmaceutical manufacturer personnel.
Speakers
Adam Buckler MPharm
VP Access Strategy, Verpora | LinkedIn
Former Lead Pharmacist at The Royal Marsden NHS Foundation Trust, bringing over 12 years of NHS oncology pharmacy experience alongside global expertise in forecasting, market access, and value-based contracting strategy.
Freddie Gough
Associate Business Consultant, Verpora | LinkedIn
Supporting the research, analysis, and development of insight-led projects exploring the real-world operational factors influencing oncology medicine utilisation and forecasting.
Advanced Oncology Pharmacist
7+ years specialist oncology experience; clinical trial set-up & chemotherapy protocol writing; currently working in GI & lung cancer clinics
Lead Pharmacist Cancer Services
8+ years oncology & aseptics experience spanning 3 major oncology centres; independent prescriber; protocol writing